Clinical Trial Detail

NCT ID NCT02914938
Title A Study of ME-401 in Subjects With CLL/SLL, FL, and B-cell Non Hodgkin's Lymphoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors MEI Pharma, Inc.
Indications

CLL/SLL

B-cell lymphoma

marginal zone B-cell lymphoma

diffuse large B-cell lymphoma

follicular lymphoma

Therapies

ME-401

ME-401 + Rituximab

Age Groups: adult senior

No variant requirements are available.